Zantac® (ranitidine) is a medication used for heartburn that reduces the amount of acid produced by the stomach. On April 1, 2020, the FDA (Food and Drug Administration) asked the manufacturers to withdraw all ranitidine products from the U.S. because of concerns that they contain a toxic contaminant N-Nitrosodimethylamine (NDMA).
NDMA is a research chemical that was produced for making rocket fuel. It was discontinued after high levels of the chemical were found in the air, water, and soil around the rocket fuel manufacturing plant.
NDMA can also be created accidentally during manufacturing processes involving chemicals called alkylamines. Apparently NDMA is created during the manufacture and storage of ranitidine, or perhaps even due to a reaction with enzymes in the body.
The World Health Organization class NDMA is as a carcinogen linked to stomach, bladder, kidney, pancreatic, colon and other cancers.
The manufacturer of Zantac® is currently facing allegations that they endangered the lives of consumers. Investigations are ongoing.
If you or a loved one has taken a product containing ranitidine and been diagnosed with cancer, please contact our office to discuss your claim.